Rubius Therapeutics (STU:5RT) Total Stockholders Equity : €14.28 Mil (As of Dec. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Total Stockholders Equity?

Rubius Therapeutics's Total Stockholders Equity for the quarter that ended in Dec. 2022 was €14.28 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Rubius Therapeutics's Book Value per Share for the quarter that ended in Dec. 2022 was €0.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Rubius Therapeutics's Debt-to-Equity for the quarter that ended in Dec. 2022 was 0.07.

Rubius Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Rubius Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics Total Stockholders Equity Chart

Rubius Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

345.45

246.79

116.36

158.22

14.28

Rubius Therapeutics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Total Stockholders Equity	Get a 7-Day Free Trial															158.22	122.26	90.38	36.95	14.28

Rubius Therapeutics (STU:5RT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Rubius Therapeutics's Book Value per Share for the quarter that ended in Dec. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(14.284	-	0)	/	90.3877
	=	0.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Rubius Therapeutics's Debt-to-Equity for the quarter that ended in Dec. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.038	+	0)	/	14.284
	=	0.07

Rubius Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Rubius Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Rubius Therapeutics (STU:5RT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

124 Washington Street, Suite 101, Foxborough, MA, USA, 02035

Website

https://www.rubiustx.com

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines